| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| RBPJ |
C2C12 (myoblasts) |
DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 6hrs |
Permissive
|
Mus musculus |
GSE37184
...
|
MA1116.1
|
| RBPJ |
C2C12 (myoblasts) |
Treatment: grown in the presence of the extracellular domain of Delta-like 1 fused to the Fc fragment of human IgG for 24 hrs; |
Permissive
|
Mus musculus |
GSE37184
...
|
MA1116.1
|
| RBPJ |
C2C12 (myoblasts) |
DAPT dissolved in DMSO (Calbiochem) was added to Fc-only dishes at a final concentration of 20uM for 24hrs |
Permissive
|
Mus musculus |
GSE37184
...
|
MA1116.1
|
| RBPJ |
F9 (embryonal carcinoma) |
Developmental stage: cycling cells (containing 95% interphase and 5% mitosis cells); |
Permissive
|
Mus musculus |
GSE45889
...
|
MA1116.1
|
| RBPJ |
F9 (embryonal carcinoma) |
Developmental stage: mitotic cells; |
Permissive
|
Mus musculus |
GSE45889
...
|
MA1116.1
|
| RBPJ |
primary murine T-ALL (acute lymphocytic leukemia) cells |
Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; |
Permissive
Robust
|
Mus musculus |
GSE61504
...
|
MA1116.1
|
| RBPJ |
primary murine T-ALL (acute lymphocytic leukemia) cells |
Tissue: spleen; Strain: C57BL/6; Subtype: GFP,CD4, CD8 positive cells; |
Permissive
Robust
|
Mus musculus |
GSE61504
...
|
MA1116.1
|
| RBPJ |
MDA-MB-157 (triple negative breast carcinoma) |
Treatment: GSI-washout; |
Permissive
|
Homo sapiens |
GSE116868
...
|
MA1116.1
|
| RBPJ |
MDA-MB-157 (triple negative breast carcinoma) |
Treatment: GSI-mock-washout; |
Permissive
|
Homo sapiens |
GSE116868
...
|
MA1116.1
|
| RBPJ |
HCC-1599(ductal breast carcinoma) |
Treatment: GSI-washout; |
Permissive
|
Homo sapiens |
GSE116871
...
|
MA1116.1
|
Showing 10 records in page 697
from 963 pages